# Robeauté

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/robeaute

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.robeaute.com
- Total disclosed funding: $28M
- Latest round: Seed (Jan 14, 2025)
- Investors on record: 7

## About

Founded in 2017 and based in Paris, France, Robeauté SAS operates as a robotic medical technology company. The company was founded by its CEO, Bertrand Duplat, and COO Joana Cartocci. In January 2024, Robeauté SAS raised USD 28 million in venture funding co-led by Plural UK Management, Cherry Ventures, Kindred Ventures, LocalGlobe, and Brainlab.

Robeauté's primary offering is a neurosurgical microrobot designed to enhance surgical precision through advanced 3D, non-linear movements and real-time data collection. This modular medical device can adapt to various applications, including electrode implantation, molecular delivery, tissue sampling, and sensor data collection, leveraging extensive research into microorganisms and custom microfabrication processes.

Robeauté operates on a revenue model based on partnerships with medical institutions and healthcare providers, facilitating the deployment of their neurosurgical microrobots.

The company plans to utilize the funding raised in January 2024 to support its entrance into the US, where it will pursue FDA approval before addressing the European regulatory authorities.

## Funding rounds

- Seed, Jan 14, 2025, $28M — Brainlab, Cherry Ventures, LocalGlobe, Apex Ventures, Think.Health Ventures, Kindred Ventures, Plural

## Investors

- Brainlab — Seed
- Cherry Ventures (https://capitalatlas.ai/funds/cherry-ventures) — Seed
- LocalGlobe (https://capitalatlas.ai/funds/localglobe) — Seed
- Apex Ventures (https://capitalatlas.ai/funds/apex-ventures) — Seed
- Think.Health Ventures (https://capitalatlas.ai/funds/think-health-ventures) — Seed
- Kindred Ventures (https://capitalatlas.ai/funds/kindred-ventures) — Seed
- Plural (https://capitalatlas.ai/funds/plural) — Seed